Where does HIV hide? A focus on the central nervous system
- PMID: 23429501
- PMCID: PMC5241183
- DOI: 10.1097/COH.0b013e32835fc601
Where does HIV hide? A focus on the central nervous system
Abstract
Purpose of review: To review the literature on infection and evolution of HIV within the brain in the context for understanding the nature of the brain reservoir and its consequences.
Recent findings: HIV-1 in the brain can evolve in separate compartments within macrophage/microglia and astrocytes. The virus adapts to the brain environment to infect these cells and brain-specific mutations can be found in nearly all genes of the virus. The virus evolves to become more neurovirulent.
Summary: The brain is an ideal reservoir for the HIV. The brain is a relatively immune privileged site and the blood-brain barrier prevents easy access to antiretroviral drugs. Further, the virus infects resident macrophages and astrocytes which are long-lived cells and causes minimal cytopathology in these cells. Hence as we move towards developing strategies for eradication of the virus from the peripheral reservoirs, it is critical that we pay close attention to the virus in the brain and develop strategies for maintaining it in a latent state failure of which could result in dire consequences.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Blackard JT. HIV compartmentalization: a review on a clinically important phenomenon. Curr HIV Res. 2012;10:133–142. - PubMed
-
- Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16. In a large muticenter cohort of HIV-infected patients it was found that the incidence of HIV-associated neurocognitive disorders remains high despite adequate anti-retroviral therapy. - PMC - PubMed
-
- Spudich S, Gisslen M, Hagberg L, et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011;204:753–760. Activated lymphocytes may be present in the CSF despite undetectable HIV in patients treated with antiretroviral drugs. - PMC - PubMed
-
- Allers K, Hutter G, Hofmann J, et al. Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood. 2011;117:2791–2799. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
